Another study by Fan et al. [104] sought to evaluate how significant the PTEN mutation is in the prognosis and drug selection of clear cell renal cell carcinoma (ccRCC), a type of kidney cancer. Here, PTEN is linked to nonpapillary renal cell carcinoma.